UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) August 24, 1998
COMMONWEALTH BIOTECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Charter)
Virginia
(State or Other 56-1641133
Jurisdiction of 001-13467 (IRS Employer
Incorporation) (Commission File Number) Identification No.)
911 East Leigh Street, Suite G-19, Richmond, Virginia 23219
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (804) 648-3820
N/A
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
Item 5. Other Events.
On August 24, 1998, Gregory A. Buck. Ph.D., who had served as the Senior
Vice-President, Chief Scientific Officer, Secretary and a Director of the
Company, submitted his resignation as a director, officer and employee of the
Company. Dr. Buck has worked for the Company for the past twelve months while on
leave of absence from Virginia Commonwealth University. He has elected to pursue
his academic interests and to terminate his affiliation with the Company in
order to do so.
Item 7. Financial Statements and Exhibits.
(a) Financial Statements of Businesses Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
Not applicable.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
COMMONWEALTH BIOTECHNOLOGIES, INC.
By: /s/ Robert B. Harris, Ph.D.
---------------------------
Robert B. Harris, Ph.D.
President
August 26, 1998
